OKOlesia Kalmukova

Olesia Kalmukova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Olesia Kalmukova has a total of 66 co-authors. Here are the top co-authors by number of shared publications:

  • Olexiy Savchuk

    Educational and Scientific Center “Іnstitute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, Kyiv, Ukraine

    6 shared publications
  • Vitalii Kyryk

    Laboratory of Pathophysiology and Immunology , Chebotarev State Institute of Gerontology of the National Academy of Medical Sciences of Ukraine , Kyiv , Ukraine

    4 shared publications
  • Mykola Dzerzhynsky

    Taras Shevchenko National University of Kyiv, Kyiv, Ukraine

    3 shared publications
  • A. V. Yurchenko

    Institute of Biology and Medicine (Education and Scientific Center), Taras Shevchenko National University, 01601, Kyiv, Ukraine

    2 shared publications
  • Alexandr Balakin

    Physical Chemistry, Vector Vitale, North Miami Beach, FL, USA

    2 shared publications
  • M. E. Dzerzhynsky

    Institute of Biology and Medicine (Education and Scientific Center), Taras Shevchenko National University, 01601, Kyiv, Ukraine

    2 shared publications

Latest Publications

  • Open Access

    Melatonin Administration Attenuates High-Fat-Diet-Induced Renal Damage in Wistar Rats

    by Olesia Kalmukova, Anastasiia Zavora, Alena Cherezova, Olexiy Savchuk, Mariia Stefanenko, Mykhailo Fedoriuk, Adam C. Jones, Valentyn Nepomnyashchy, Mykola Dzerzhynskyi, Marharyta Semenikhina, et al.

    Obesity is a major contributor to kidney injury, in part through circadian rhythms disruption and oxidative stress. Melatonin, a circadian clock regulator, has been proposed as a protective agent against metabolic and renal complications. We investigated the effects of chronic melatonin supplementation on kidney injury and circadian regulation in a rat obesity model. We hypothesized that melatonin administration ameliorates kidney injury induced by a high-calorie diet. Male Wistar rats were fed a normal or hypercaloric diet for six weeks, followed by seven weeks of vehicle or melatonin treatment (30 mg/kg/day in drinking water); biometric parameters and renal injury were assessed. Obese rats exhibited increased visceral adiposity, elevated resistin, renal hypertrophy, fibrosis, tubular degeneration, and glomerular injury, accompanied by higher KIM-1 levels. Melatonin attenuated renal fibrosis, reduced KIM-1, TGFβ, and TNFR1 levels, improved proximal tubule and glomerular damage, and lowered adipose TNF-α levels in the obese groups. In lean controls, melatonin increased nuclear BMAL1 levels, while in obese rats this effect was blunted; of note, BMAL1 accumulated in distal tubular cytoplasm in both melatonin-treated groups. These findings suggest that melatonin mitigates obesity-induced renal pathology through anti-fibrotic inflammation-related mechanisms, while also revealing a novel link between circadian disruption and kidney injury. Our results support melatonin as a therapeutic agent for obesity-related renal disease.


  • Open Access

    Zn64 aspartate modulates inflammation, tryptophan metabolism, and pancreatic function in diet-induced obesity

    by Max Temnik, Sergey Gurin, Leonid Magidenko, Alexandr Balakin, Roman Byshovets, Olesia Kalmukova, Tetiana Vovk, Tetiana Halenova, Nataliia Raksha, Olexiy Savchuk

    Obesity-induced metabolic syndrome is characterized by chronic inflammation, hormonal imbalance, and altered neurotransmitter metabolism. Zinc plays a critical role in immune regulation and energy balance; however, the effects of isotopically modified chelate complexes in metabolic functions remain unexplored. This study investigated the therapeutic effects of isotopically enriched Zn64 Aspartate in a rat model of diet-induced obesity, focusing on inflammation, adipokine secretion, and tryptophan metabolism across serum, brain, duodenum, the pancreas, and adipose tissues. Male Wistar rats were fed a high-fat diet to induce obesity and treated with Zn64 Aspartate. Proinflammatory and anti-inflammatory cytokine levels, resistin, ghrelin, serotonin, tryptophan concentrations, and enzymatic activities of tryptophan hydroxylase (TPH), indoleamine 2,3-dioxygenase (IDO), and monoamine oxidase (MAO) were analyzed. Zn64 Aspartate significantly reduced pro-inflammatory cytokines and resistin levels while normalizing ghrelin. It enhanced serotonin levels and modulated TPH, IDO, and MAO activities in a tissue-specific manner, favoring serotonergic over kynurenine pathway metabolism. A decrease in pancreatic fibrosis, glycogen content, and an increase in the number of insulin-positive β-cells were observed in obese rats treated with Zn64 Aspartate, compared with the obese group. Conclusively, Zn64 Aspartate shows promise as a metabolic modulator by attenuating inflammation and restoring neuroendocrine balance in obesity. Further studies are warranted to validate its therapeutic potential.


  • Open Access

    Therapeutic potential of zinc 64Zn aspartate for obesity management: impact on oxidative stress, lipid metabolism, pancreas and liver in high-calorie diet model

    by Max Temnik, Sergey Gurin, Alexandr Balakin, Roman Byshovets, Olesia Kalmukova, Tetiana Vovk, Tetiana Halenova, Nataliia Raksha, Tetyana Falalyeyeva, Olexiy Savchuk

    Zinc is a critical micronutrient that plays multifaceted roles in oxidative stress management, lipid metabolism, pancreatic function, and liver health, which are all closely interconnected with obesity. Maintaining adequate zinc levels is essential for overall metabolic health and proper functioning of these vital systems. The investigational new drug complex of zinc-64 aspartate (KLS-1 or 64Zn-aspartate) was evaluated in this study as a pharmaceutical agent targeting oxidative stress and lipid metabolism using rodent model of obesity. KLS-1 is the isotopically modified zinc aspartate in which stable (non-radioactive) 64Zn atoms were enriched to exceed 99% atomic fraction of total zinc, as compared to natural isotopic ratio of 64Zn of 48.6%. In this paper, we discuss our findings and the effects rendered by KLS-1 on lipid metabolism, pancreas and liver function. This study was conducted on outbred rats, which were divided into four experimental groups: 1) the control group consuming standard food (3.81 kcal/g), 2) the obese group consuming a high-calorie diet (5.35 kcal/g), 3) the obese group consuming a high-calorie diet (5.35 kcal/g) treated with intragastric administration of 64Zn- aspartate at a dose of 4.5 mg per animal during 6 weeks (the obese rats), 4) the group consuming standard food diet (3.81 kcal/g) with 64Zn- aspartate form administration. The obese rats treated with 64Zn-64 stable isotope demonstrated decreased area of the hepatocytes, insulin and glucose levels in serum; increased catalase and superoxide dismutase activity, and area of pancreatic islets in comparison with the obese group. The study shows that 64Zn-aspartate is effective as a therapeutic agent for obesity management, significantly reducing body mass, improving histopathological changes in the pancreas and liver and normalizing oxidative stress in high-calorie diet animal models. These findings suggest that 64Zn- aspartate may be a promising monotherapy or adjunct treatment for obesity, offering benefits in weight reduction, organ protection, and antioxidant balance.


  • Open Access

    Peptide pool instability of precancerous lesions in rats with chronic pancreatitis model and/or without type 1 diabetes mellitus

    by Sergii Sukhodolia, Olesia Kalmukova, Natalia Raksha, Anatolyi Sukhodolia, Olena Kuryk, Olexiy Savchuk

    The search for early and minimally invasive diagnostic approaches to pancreatic cancer (PC) remains an important issue. One of the most promising directions is to find a sensitive key in the metabolic changes during widespread causes of PC, i.e., chronic pancreatitis (CP) and diabetes mellitus (DM). The main objective of this study was to analyze the peptide pools in the blood plasma and pancreas of rats with modeling of CP and/or without type 1 DM in association with pancreas histopathological grading features. The study was conducted on white non-linear male rats, divided into 3 groups: 1st group: control, 2nd group: rats with cerulein-stimulated CP, and 3rd group: rats with CP and streptozotocin-inducible type 1 DM. Total protein and peptide content were determined in the pancreas and blood plasma. The peptide pools were fractionated using size-exclusion chromatography. Rats with CP showed a high degree of fibrosis in the pancreas and grade 1 ductal pancreatic intraepithelial neoplasia (PanIN), associated with decreased total peptides in the pancreas. In rats with CP and DM, 2nd and 3rd grade PanIN with pronounced acinar metaplasia was observed in association with decreasing total pancreatic protein and peptide pools. While there was a decrease in total protein and an increase in total peptide in blood serum, the changes were more pronounced in rats with CP and DM. A study revealed both qualitative and quantitative differences in the distribution of peptide pools in 2 groups with pathologies. Qualitatively, plasma samples from pathological groups exhibited an increased number of peaks. Quantitatively, there was a higher proportion of peptides with molecular weights exceeding 700 Da observed in both plasma and pancreas. The analysis of peptide pools obtained from plasma and PanIN development demonstrated that the peptide pool can serve as an early and complementary indicator of PC emergence.

  • Open Access

    DETECTION OF P16/KI-67 MARKERS IN THE DETECTION OF CERVICAL INTRAEPITHELIAL NEOPLASIA

    by Maryna Novokhatska, Olesia Kalmukova, Nataliia Skrypnyk, Oksana Nebyltsova, Kyiv Medical Laboratory Llc Synevo Ukraine, Олеся Калмикова, Наталія Скрипник

    B a c k g r o u n d . In recent years, Ukraine has experienced an unfavorable epidemiological situation concerning sexually transmitted diseases. One rapidly spreading infection is genital human papillomavirus (HPV). Convincing research has identified human papillomavirus (HPV) as a significant factor in the development of malignant transformations in the cervix. The study of the molecular pathogenesis associated with HPV-related neoplasms has led to the discovery of biomarkers aiding in the diagnosis of High-grade Squamous Intraepithelial Lesion (HSIL) of the cervix. Including the biomarkers p16/Ki-67 in the investigation enhances sensitivity in detecting HSIL in women. Additionally, it is pertinent to further analyze the effectiveness of using an additional semi-quantitative scale to assess the results of immunocytochemical detection of p16/Ki-67. M e t h o d s . The research was conducted on biological material from cervical smears using liquid-based cytology. Techniques included Papanicolaou staining, HPV detection, and immunocytochemical staining against p16/Ki-67. The sample comprised 90 women divided into three age groups, each categorized based on criteria such as HPV presence/absence, Bethesda classification of dysplasia, and negative/positive p16/Ki-67 results. Intensity of staining was further scored on a scale in the corresponding location of positive reactions in the nucleus or cytoplasm. R e s u l t s . The study revealed that immunocytochemical markers p16 and Ki-67 identified women with intraepithelial lesions, especially in cases with positive HPV results and no dysplastic changes in the Pap test. The intensity of immunocytochemical staining for p16 and Ki-67 varied directly with the detected degree of dysplasia. C o n c l u s i o n s . A direct correlation was observed between the severity of dysplasia established by Bethesda classification and the intensity of immunocytochemical staining for p16 and Ki-67. These findings provide an opportunity for further exploration of staining intensity in the presence of immunocytochemical markers p16 and Ki-67 for their potential use in the comprehensive interpretation of Pap test results and the precise identification of dysplasia in ambiguous diagnostic samples.

  • Open Access

    CIRCADIAN RHYTHMS AND PERSONALIZED STRATEGIES FOR ANTI-AGING THERAPIES

    by Olesia Kalmukova, Vitalii Kyryk, Mykola Dzerzhynsky

    Background. Nowadays personalized medicine is actively developing and consists of individual approaches during patients' treatment, diagnoses and prognoses. Since the first use of DNA sequence analysis in 2009, many other directions and methods for precision medicine have been proposed, including metabolome, transcriptome, proteome, microbiome analysis etc., which reflect internal factors of organisms. Moreover, to take into account environmental influence on organisms including day/night activity, feeding and physical training regime, it was proposed to apply the descriptions of circadian system rhythmicity of each patient. Also, with organism aging, the sensitivity to external factors is raised that emphasizes the importance of the chronobiological approach in anti-aging concept. In this review we discussed available ways of the application of circadian system parameters to analyze human metabolic state. Methods. Search strategy: PubMed, Scopus, DOAJ (Directory of Open Access Journals) and Google Scholar were used to search for original research and articles review; no abstracts from meeting reports have been cited. ClinicalTrials.gov was used to search for clinical studies. Search terms included “chronotherapy”, “circadian system”, and “chronobiology”. Results. According to personalized medicine, the analysis of circadian system in the case of each patient is necessary as circadian rhythmicity varies in every person. Taking into account the peculiarities of patient’s circadian system it will be easy to choose the best time for drug administration resulting in high efficacy and low side effects. The analysis of circadian system can be performed on molecular, physiological and systemic (general, metabolic and inflammation markers) levels. There was shown the increase in the number of clinical trials which are based on the use of chronobiological approach during the treatment of different pathologies that increase with aging: depression, insomnia, metabolic and cardiovascular disease, cancer. More than 1,000 clinical trials involving circadian interventions and chronobiology have been registered worldwide. Conclusion. Chronobiological approach can be used as an additional measure to anti-aging therapy to diagnose metabolic state, to choose more effective treatment time as well as in preventive healthcare in terms of personalized medicine.


  • Open Access

    Low-Molecular-Mass Fragments of Collagen Improve Parameters Related to Mass and Inflammation of the Adipose Tissue in the Obese Rat

    by Olesia Kalmukova, Nataliia Raksha, Tetiana Vovk, Tetiana Halenova, Mykola Dzerzhynsky, Dinko Mitrecic, Olexiy Savchuk, Ludmila Ostapchenko

    Research background. Despite clearly recognized links between increased body mass and increased risk for various pathological conditions, therapeutic options to treat obesity are still very limited. The aim of the present study is to explore the effect of low-molecular-mass collagen fragments obtained from the scales of Antarctic wild marine fish on rats’ visceral and subcutaneous white adipose tissue in a high-calorie diet-induced obesity model. Experimental approach. The study was conducted on outbred rats, which were divided into 3 experimental groups: (i) control, consuming standard food (3.81 kcal/g), (ii) obese group, consuming a high-calorie diet (5.35 kcal/g), and (iii) obese group, consuming a high-calorie diet (5.35 kcal/g) with intragastric administration of low-molecular-mass collagen fragments (at a dose 1 g/kg of body mass during 6 weeks). Low–molecular-mass collagen fragments were obtained by a procedure that included collagen extraction from fish scales and enzymatic hydrolysis with pepsin. Apart from hematoxylin and eosin staining, fibrosis level was assessed by histochemical Van Gieson’s trichrome picrofuchsin staining, and mast cells were analysed by toluidine blue O staining. Results and conclusions. Group treated with low-molecular-mass fragments of collagen exhibited decreased rate of mass gain, relative mass, area occupied by collagen fibre of both visceral and subcutaneous adipose tissue, and cross-sectional area of both visceral and subcutaneous adipocytes. Treatment with low-molecular-mass fragments of collagen reduced the infiltration of immune cells, number of mast cells and their redistribution back to the septa. This was also accompanied by a decreased number of the crown-like structures formed by the immune cells, which are markers of chronic inflammation that accompanies obesity. Novelty and scientific contribution. This is the first study that reports the anti-obesity effect of low-molecular-mass fragments produced as a result of controlled hydrolysis of collagen from the scales of Antarctic wild marine fish in the in vivo model. Another novelty of this work is the observation that the tested collagen fragments not only reduce the body mass, but also improve the morphological and inflammatory parameters (decrease in the number of crown-like structures, immune cell infiltration, fibrosis and mast cells). Altogether, our work suggests that low-molecular-mass collagen fragments are a promising candidate for amelioration of some comorbidities linked to obesity.


  • Open Access

    MELATONIN IMPROVES SPLEEN HISTOPHYSIOLOGY OF RATS WITH DIET-INDUCED OBESITY: CHRONOTHERAPY APPROACH

    by Olesia Kalmukova, Hanna Shemetova, Nataliia Skrypnyk, Olexiy Savchuk, Mykola Dzerzhynsky

    One of the most commoncharacteristics of obesity is the development of a systemic low-grade proinflammatory state in the entire body, including the immune organs. Spleen enlargement during diet-induced obesity contributes to the development of chronic inflammation. Melatonin due to immunomodulatory, antioxidant, and systemic metabolic rolesis proposed to be an effective candidate for anti-obesity therapy. As immune systems demonstrate pronounced circadian rhythmicity and immune cells have different types of melatonin receptors, a chronotherapeutic approach might be used to choose the most effective regimes of melatonin administration for the correction of obesity-provoked damage to the spleen. Thus, the main goal of our research was the analysis of the rats' spleen histophysiology during the development of high-calorie diet-inducedobesity (HCD) after administering melatonin daily at different times (morning or evening). Melatonin was administered by gavage for 7 weeks in the dose of 30 mg/kg 1 h before lights-off (HCD ZT11, M ZT11, evening), or 1 h after lights-on (HCD ZT01, M ZT01, morning). For assessment of the morpho-functional state of the spleen,the histopathological evaluation of red and white pulp in different zones of lymphoid follicles was implemented. It was observed that obesity development wasaccompaniedbyhyperemia and vessel dilatation in the red pulp; while in the white pulp notable deformation of germinal centers and destroyed borders between zones of lymphoid follicles were noticed.The HCD group demonstrated a decrease inthe relative amount of the white pulp, the crosssectional area of germinal centers, and the cross-sectional area of the marginal zone; whilethe increased relative amount of red pulp and marginal zone/germinal centers ratiowere detected compared with control. Melatonin administration to obese rats increases the relative amount of the white pulp (HCD ZT11 group), the cross-sectional area of germinal centers (HCD ZT01 and HCD ZT11 groups), and the cross-sectional area of the marginal zone (HCD ZT11 group), and decreasesmarginal zone/germinal centers ratio (HCD ZT01 group) in comparison with the HCD group.Also,it was demonstrated that a choice between the morning or evening regimes of the melatonin treatment did not affect the histophysiology of the spleen in rats receivingthe standard diet (M ZT01 and M ZT11 groups). These results indicate that melatonin can be considered to be a powerful potential therapeutic agent for the amelioration of obesity-induced changes in the spleen.

  • Open Access

    Variable Beige Adipocyte Morphology in Obese Rats by Different Times of Melatonin Administration

    by Olesia Kalmukova, Alona Yurchenko, Olexii Savchuk, Mykola Dzerzhynsky

    This study aimed to evaluate changes in beige adipocytes at different times of melatonin administration, in the morning (ZT01) or in the evening (ZT11), at 30 mg/kg daily by gavage for 7 weeks or continuously with drinking water in the term of high-calorie diet-induced obesity (HCD). Melatonin received at ZT11 or with drinking water resulted in an increased area of the browning zone in the subcutaneous white adipose tissue (sWAT), even in rats with HCD (compared with Control or HCD, respectively). The beige adipocyte and lipid droplet area after melatonin use were reduced compared to those with HCD and Control, in all administration modes (group ZT01 showed smaller changes compared to ZT11 or with drinking water groups). The fibrosis level decreased and significantly differed in HCD ZT01, HCD ZT11, and HCD water compared to that in HCD; moreover, the lowest value determined in HCD water, reached the control parameters. Furthermore, the IL-1b and IL-8 level was decreased in the HCD groups under melatonin treatment at ZT11 or with drinking water compared to that in HCD. The obtained results suggest that melatonin promotes sWAT browning in rats with diet-induced obesity and influences morphological signs of normal rats depending on the time of administration. Different functional activity of beige adipocytes was observed after melatonin was used depending on the time of administration, resulting in heat production and lipolysis (the relative mass of visceral fat was likewise diminished). More rapid browning was observed when melatonin treatment was performed at 1 h before lights-off (ZT11) or continuously via drinking water. Melatonin acted on beige adipocytes of obese rats through changing some parameters such as the area of adipocytes and lipid drops, the number of lipid drops, the relative area browning of sWAT, and the level of tissue fibrosis.

  • Changes in the Inflammatory Status in White Adipose Tissue of Rats with Diet-Induced Obesity at Different Regimens of Melatonin Administration

    by O. O. Kalmukova, A. V. Yurchenko, A. M. Savchuk, M. E. Dzerzhynsky

    The effects of different regimens (morning and evening) of melatonin administration (30 mg/kg/day during 7 weeks) on the course of inflammation proces